4DMedical is a global medical technology company aiming to change the outcome for patients with lung disease by revolutionizing respiratory imaging and ventilation analysis.
With offices in Melbourne, Australia and Los Angeles, California, we have successfully proven and patented our XV Technology™ through years of studies and trials, completed by some of the most talented minds in medical technology.
4DMedical is a global medical technology company that creates revolutionary FDA-cleared four-dimensional lung imaging technology. Products include XV LVAS® lung imaging software as well as the XV Scanner™*, the world’s first dedicated lung function scanner—featuring zero-contrast imaging. XV technology delivers detailed, actionable insights to airflow, lung structure, and regional lung function through a patient’s complete breath cycle. XV Lung Ventilation Analysis Software (XV LVAS) is an innovative, first of its kind imaging modality that quantitatively measures regional lung function. A simple protocol, using existing hospital fluoroscopy, delivers more accurate and detailed information, with less impact to patients. Combining X-ray imaging with a proprietary flow velocity measurement technique, XV LVAS gives clinicians a clearer, more complete picture of lung health—across pulmonary disorders including asthma, COPD, cystic fibrosis, and cancer. 4DMedical continues to collaborate with many of the world’s leading research institutions—to better advance the diagnosis, treatment, and outcomes of patients with pulmonary disease.
4DMedical is dedicated to bringing groundbreaking new capabilities and diagnostic possibilities to respiratory imaging and ventilation analysis. Our growing line of software and hardware technologies give clinicians unprecedented detail and actionable insights to airflow, lung structure, and regional lung function—through a patient’s complete breath cycle. 4DMedical technologies provide a much more complete picture of functional lung health across pulmonary disorders including asthma, COPD, cystic fibrosis, and cancer.
4DMedical products include XV LVAS® and CT LVAS™ lung image analysis software which operate on a software as a service (SaaS) model. These provide clinicians with rich, quantitative, functional lung health metrics and information—from images uploaded from existing hospital fluoroscopy or CT scanners, respectively. We also created the XV Scanner, the world’s first dedicated lung function scanner—featuring zero-contrast imaging.
4DMedical collaborates with many of the world’s leading research institutions—to better advance the diagnosis, treatment, and outcomes of patients with pulmonary disease. With offices in Melbourne, Australia and Los Angeles, California, we have successfully proven and patented our unique lung imaging technologies through years of studies and trials—conducted by some of the most talented minds in medical technology.
*Not yet available for commercial sale
Our mission is to improve global health by providing unique and non-invasive imaging technologies that enable unprecedented insight into pulmonary functioning, critical in the analysis and management of respiratory diseases.
A world where people with lung disease have better outcomes and more hope.
We work to provide better information to patients and doctors. We do this to empower better decisions, and to bring about improved health outcomes for the millions of people around the world suffering from lung disease.
We believe in the humanity of our mission and are mindful of its importance.
We drive innovation through unique technologies which deliver unprecedented insight to patients and doctors. We strive to lead the way, improving global health through excellence and continuous improvement not only through our products, but in everything we do.
Impact is the driving force behind every innovation we create. We push boundaries to develop clinically useful technologies that offer the greatest, positive impact. We measure our impact through the number of lives we touch, and the depth of the benefit that we deliver to them.
